Gentel Biosciences

Gentel® Obtains License From Agnitio For Protein Microarray Technology

Gentel plans to incorporate ultrasonic coating technology into its manufacturing process for standard microarray slides as well as for its recently developed 96-well microarray platform, SilverQuant®96.

“The technology is highly scalable and will enable us to manufacture the number and type of protein microarray slides required for protein biomarker discovery, validation, and diagnostics,” said Alex Vodenlich, Gentel's President and CEO. “The acquisition of this intellectual property further extends Gentel’s position as the market leading protein microarray company.”

The ultrasonic coating technology is covered by a suite of issued and pending US and international patents.

ABOUT AGNITIO SCIENCE AND TECHNOLOGY

Agnitio Science & Technology is one of the leading microfluidics technology and information infrastructure providers to the global healthcare and life science industry. Visit www.agnitiost.com for more information.